🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Sreepriya Prasannan

Sreepriya Prasannan

Life Science Journalist & Editor

Sreepriya Prasannan is the Founder and Lead Editor of Priya Life Science. With a deep passion for the Irish pharmaceutical and MedTech sectors, she specializes in sharing actionable career insights, digital regulatory trends, and GMP compliance strategies.

191
Articles
7
Topics
1219
Min Published
Filter: All 191 Industry 75 Regulatory Affairs 42 Pharmaceutical 25 Biotechnology 16 MedTech 16 LinkedIn 12 Clinical Trials 5

All Articles

Page 8 of 16 — 191 articles
Addiction Counsellors of Ireland Launch Strategic Plan 2026-2029 to Prepare for CORU Regulation
Regulatory Affairs
Addiction Counsellors of Ireland Launch Strategic Plan 2026-2029 to Prepare for CORU Regulation
Presented at the ACI’s Annual General Meeting in Carlow by Minister Jennifer Murnane O’Connor and ACI Board member John Devlin, the new three-year strategy focuses on workforce recognition, professional development, and regulatory transitions.
28 Jun 2026 4 min
Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Industry
Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
As the Health Research Board (HRB) reports a record 8,798 alcohol treatment cases in 2025, Minister Murnane O’Connor has announced funding for an evidence-based digital intervention tool under the Sláintecare Integration Innovation Fund.
28 Jun 2026 4 min
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
Industry
EU PEACEPLUS Funds €2.4M All-Island Public Health Knowledge Hub to Unite Cross-Border Population Data
Launched in Dundalk, the three-year Public Health Knowledge Hub (PHKH) project brings together the Institute of Public Health, Trinity College Dublin, and Ulster University to build the first-ever harmonised cross-border public health data portal.
28 Jun 2026 4 min
The Irish Distortion: How Multinational Pharma Giants Warped the EU’s Economic Landscape
Pharmaceutical
The Irish Distortion: How Multinational Pharma Giants Warped the EU’s Economic Landscape
Ireland’s status as a corporate hub for global pharmaceutical multinationals has created a unique statistical paradox-masking true economic health and dragging the EU’s GDP into negative territory in the first quarter of 2026. We examine the tax structures, tariff-hedging inventory builds, and supply chain strategies driving this anomaly.
28 Jun 2026 5 min
Setting Up a Life Science PR Infrastructure from Scratch: The Operational Blueprint for Pharma & Biotech
Biotechnology
Setting Up a Life Science PR Infrastructure from Scratch: The Operational Blueprint for Pharma & Biotech
A complete, step-by-step operational guide for establishing a compliant, highly effective PR department inside a life science, pharmaceutical, or biotechnology firm.
27 Jun 2026 3 min
UK Launches £85M Obesity Innovation Mission: 12 Pioneering Projects to Test Digital Interventions and Next-Gen GLP-1 Delivery
Regulatory Affairs
UK Launches £85M Obesity Innovation Mission: 12 Pioneering Projects to Test Digital Interventions and Next-Gen GLP-1 Delivery
The UK government and industry partners have unveiled a £85 million funding package for 12 pioneering projects aimed at transforming obesity care, integrating digital tools, and optimizing GLP-1 clinical pathways.
27 Jun 2026 3 min
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
27 Jun 2026 22 min
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
LinkedIn
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
A practitioner-level guide to building genuine professional authority on LinkedIn as a pharmaceutical, biotech, or MedTech professional. Covers profile architecture, content strategy, engagement tactics, thought leadership frameworks, and the exact playbooks used by the most followed life science voices on the platform.
27 Jun 2026 20 min
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
Regulatory Affairs
Ireland Family Reunification 2026: The Complete Guide to Financial Thresholds, Waiting Periods, How to Apply, and What Every Sponsor Must Know
A detailed, practical guide to Ireland's Non-EEA Family Reunification Policy as updated in 2026. Covers the new financial thresholds for all sponsor categories, country-specific waiting periods, step-by-step application process, and a comprehensive pre-application checklist - essential reading for pharmacists, healthcare workers, and life science professionals bringing family to Ireland.
27 Jun 2026 18 min
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
Regulatory Affairs
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.
25 Jun 2026 4 min
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
25 Jun 2026 4 min
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Regulatory Affairs
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Eli Lilly has successfully brought its LillyDirect service to the UK. Adapted to comply with strict local regulations, the service partners with regulated healthcare organizations to offer secure, anti-counterfeit delivery of high-demand therapies like Mounjaro directly to patients' doors.
25 Jun 2026 4 min